880 results
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-28 October 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 25/10/2021 to 28/10/2021, Last updated: 02/08/2022 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 14-15 June 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 14/06/2022 to 15/06/2022, Last updated: 22/07/2022 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 12-14 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 12/07/2022 to 14/07/2022, Last updated: 12/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 24-27 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/10/2022 to 27/10/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 November - 1 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 28/11/2022 to 01/12/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 August - 1 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 29/08/2022 to 01/09/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 10-12 May 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/05/2022 to 12/05/2022, Last updated: 24/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 07/06/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 3-5 November 2021
European Medicines Agency, Amsterdam, the Netherlands, from 03/11/2021 to 05/11/2021, Last updated: 21/01/2022 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 5-7 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/10/2021 to 07/10/2021, Last updated: 07/12/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 November-2 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 29/11/2021 to 02/12/2021, Last updated: 29/11/2021 -
List item
News: Call for expressions of interest for civil society representatives to participate in work of EMA
PRAC, Last updated: 27/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 15-17 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 15/06/2021 to 17/06/2021, Last updated: 30/07/2021 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 13-15 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 13/04/2021 to 15/04/2021, Last updated: 24/06/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2021 to 10/06/2021, Last updated: 07/06/2021 -
List item
European Medicines Agency / AnimalhealthEurope veterinary medicines info day 2021
Virtual meeting, 25/03/2021, Last updated: 14/04/2021 -
List item
Press briefing on the conclusion of the investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events by the Pharmacovigilance Risk Assessment Committee (PRAC)
Virtual meeting, 18/03/2021, Last updated: 19/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
Committee for Medicinal Products for Veterinary Use (CVMP): 3-5 November 2020
Virtual meeting, from 03/11/2020 to 05/11/2020, Last updated: 18/01/2021